This is a routine sell-to-cover transaction for tax withholding on vested equity, not a discretionary insider sale. No bearish signal. Monitor for any subsequent Form 4 filings showing open-market sales by the same insider, which would be more informative.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 3 $7.09entry
- T+1 · 6mo ago +3.10%α +2.70% · $7.31
- T+5 · 5mo ago −0.85%α +2.97% · $7.03
- T+20 · 5mo ago +29.76%α +30.76% · $9.20
- T+60 · 3mo ago −10.30%α −12.79% · $6.36
Price Chart
How similar events traded
Executive Summary
Adam Vandervoort, an officer of Teladoc Health, filed a Form 144 notice of intent to sell 7,906 shares of common stock, valued at approximately $60,299. The sale is to cover a tax obligation from a vested equity award distribution, with the shares acquired via restricted stock vesting on June 1, 2026. This is a routine, tax-motivated sell-to-cover transaction by an insider, not a discretionary open-market sale, and carries minimal directional signal for the stock.
Key Facts
- Insider Adam Vandervoort (Officer) filed Form 144 on June 2, 2026.
- Proposed sale of 7,906 shares of common stock, approximate value $60,299.
- Shares acquired via restricted stock vesting on June 1, 2026.
- Sale is to cover a tax obligation from settlement of a vested equity award distribution.
- Selling agent: Fidelity Brokerage Services LLC.
- Stock listed on NYSE; market cap ~$1.4B.
Financial Impact
Proceeds of ~$60,299 from sale of 7,906 shares, representing a small fraction of the officer's likely total holdings and ~0.004% of market cap.
Risk Factors
- Insider may still execute additional discretionary sales in the future, though this filing does not indicate that.
- Form 144 is an intent to sell; the sale may not be completed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-004276 |
| Document: 0001959173-26-004276-index.html | 0001959173-26-004276 |
| Document: 0001959173-26-004276.txt | 0001959173-26-004276 |
Track record
24 reports on TDOC
3 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +2.52% at T+1 after the Oct 28, 2026 report. 3 of 3 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $8.60 Now $8.70 +1.22% settles Nov 17
- Nov 6, 202610d ago 144 Neutral 3/10 Entry $8.77 to $8.98 Now $8.70 −0.80% ▲ +2.39% +0.03% vs SPY
- Nov 3, 202613d ago 3 / PRESS-RELEASE Neutral 2/10 Entry $9.70 to $9.41 Now $8.70 −10.31% ▼ −2.99% +1.42% vs SPY
- Nov 3, 202614d ago PTAB Trial Neutral 3/10 Entry $8.89 to $9.70 Now $8.70 −2.14% ▲ +9.11% +7.46% vs SPY
- Oct 28, 202619d ago Press Release Bearish 6/10 No price data
- Oct 28, 202619d ago 8-K Bearish 6/10 Entry $8.73 to $8.51 Now $8.70 +0.34% ▲ +2.52% +0.75% vs SPY
- Oct 28, 202620d ago PTAB Trial Neutral 3/10 Entry $8.73 to $8.51 Now $8.70 −0.34% ▼ −2.52% −0.75% vs SPY
- Oct 8, 20265w ago SC 13G Neutral 3/10 Entry $5.54 to $5.77 Now $8.70 +57.04% ▲ +4.15% +3.55% vs SPY
- Sep 25, 20267w ago 8-K Neutral 3/10 Entry $6.09 to $5.89 Now $8.70 +42.86% ▼ −3.28% −2.54% vs SPY
- Sep 11, 20269w ago 144 Neutral 2/10 Entry $6.16 to $6.50 Now $8.70 +41.23% ▲ +5.52% +5.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers